Cargando…
Improving the calling of non-invasive prenatal testing on 13-/18-/21-trisomy by support vector machine discrimination
With the advance of next-generation sequencing (NGS) technologies, non-invasive prenatal testing (NIPT) has been developed and employed in fetal aneuploidy screening on 13-/18-/21-trisomies through detecting cell-free fetal DNA (cffDNA) in maternal blood. Although Z-test is widely used in NIPT NGS d...
Autores principales: | Yang, Jianfeng, Ding, Xiaofan, Zhu, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281214/ https://www.ncbi.nlm.nih.gov/pubmed/30517156 http://dx.doi.org/10.1371/journal.pone.0207840 |
Ejemplares similares
-
An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21
por: Sun, Xiaohan, et al.
Publicado: (2019) -
Detection of trisomies 13, 18 and 21 using non-invasive prenatal testing
por: Qiang, Rong, et al.
Publicado: (2017) -
Performance of non-invasive prenatal testing for trisomies 21 and 18 in twin pregnancies
por: Yang, Jiexia, et al.
Publicado: (2018) -
Clinical evaluation of the IONA test: a non‐invasive prenatal screening test for trisomies 21, 18 and 13
por: Papageorghiou, A. T., et al.
Publicado: (2015) -
Recommended practice for laboratory reporting of non‐invasive prenatal testing of trisomies 13, 18 and 21: a consensus opinion
por: Deans, Zandra C., et al.
Publicado: (2017)